Double blinded randomized placebo controlled trial to examine if intake of 5-aminolevulinic acid supplement can improve clinical symptoms of individuals with Autism Spectrum Disorder
Not Applicable
- Conditions
- Autism spectrum disorder
- Registration Number
- JPRN-UMIN000034939
- Lead Sponsor
- Research Center for Child Mental Development, University of Fukui
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
Not provided
Exclusion Criteria
1.Persons who can not agree on their own will 2.As a result of clinical evaluation, those who do not fall under the diagnosis of autistic spectrum disorder 3.Persons who fall under fragile X syndrome 4.Persons who merge neurological diseases such as epilepsy 5.Person who merges liver abnormality / inflammatory disease 6.Patients with drug allergies such as iron allergy 7.Patients complicated with porphyria 8.Persons who participated in other clinical trials within 3 months 9.Persons who have been judged by the principal investigator as inappropriate subject
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method